Cellebrite DI Ltd. (CLBT) Cash Flow Statement
Cellebrite DI Ltd. (CLBT) generated $157.6M of operating cash flow over the twelve months to 2026-06-30, spent $13.4M on capital expenditure and had free cash flow of $144.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLBTCellebrite DI Ltd.Follow CLBT — free
—
Price chart with a free account
- Market cap
- 3.0B
- P/E TTM
- 52.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 36.1 | 20.6 | 102.1 | 132.2 | 173.5 | 157.6 | |
| Capital expenditure | 5.1 | 6.9 | 5.2 | 8.6 | 13.2 | -13.4 | |
| Free cash flow | 30.9 | 13.7 | 96.8 | 123.6 | 160.3 | 144.2 | |
| Dividends paid | 100.0 | 0.0 | 0.0 | — | — | — | |
| Share repurchases | 0.0 | 0.0 | — | — | — | — | |
| Stock-based compensation | 6.5 | 13.7 | 19.0 | 30.6 | 44.9 | — |
USD millions · SEC XBRL
Cellebrite DI Ltd. — questions
- What is Cellebrite DI Ltd.'s operating cash flow?
- $157.6M over the twelve months to 2026-06-30.
- How much does Cellebrite DI Ltd. spend on capital expenditure?
- $13.4M over the twelve months to 2026-06-30.
- What is Cellebrite DI Ltd.'s free cash flow?
- $144.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Cellebrite DI Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.